BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olén O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT, Ludvigsson JF. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.Lancet. 2020;395:123-131. [PMID: 31929014 DOI: 10.1016/S0140-6736(19)32545-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 18] [Article Influence: 32.0] [Reference Citation Analysis]
Number Citing Articles
1 Yalchin M, Baker AM, Graham TA, Hart A. Predicting Colorectal Cancer Occurrence in IBD. Cancers (Basel) 2021;13:2908. [PMID: 34200768 DOI: 10.3390/cancers13122908] [Reference Citation Analysis]
2 Ali H. Future incidence and mortality of colorectal carcinoma in the United States: an updated overview of risk factors and preventative measures. Exploration of Medicine. [DOI: 10.37349/emed.2021.00063] [Reference Citation Analysis]
3 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Reference Citation Analysis]
4 Wijnands AM, Mahmoud R, Lutgens MWMD, Oldenburg B. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives. Eur J Intern Med 2021;93:35-41. [PMID: 34481721 DOI: 10.1016/j.ejim.2021.08.010] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Axelrad JE, Shah SC. Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era. Therap Adv Gastroenterol 2020;13:1756284820920779. [PMID: 32523622 DOI: 10.1177/1756284820920779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Khakoo NS, Ioannou S, Khakoo NS, Vedantam S, Pearlman M. Impact of Obesity on Inflammatory Bowel Disease. Curr Gastroenterol Rep 2022. [PMID: 35150406 DOI: 10.1007/s11894-022-00840-x] [Reference Citation Analysis]
7 Cutone A, Ianiro G, Lepanto MS, Rosa L, Valenti P, Bonaccorsi di Patti MC, Musci G. Lactoferrin in the Prevention and Treatment of Intestinal Inflammatory Pathologies Associated with Colorectal Cancer Development. Cancers (Basel) 2020;12:E3806. [PMID: 33348646 DOI: 10.3390/cancers12123806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Clarisse D, Beck IM. New Tricks of Our Old Friend the Glucocorticoid Receptor: From Combating Ulcerative Colitis to Preventing Associated Colorectal Cancer. Cell Mol Gastroenterol Hepatol 2021;11:1541-2. [PMID: 33684386 DOI: 10.1016/j.jcmgh.2021.02.005] [Reference Citation Analysis]
9 Yu J, Wang S, Yuan H, Qiao T, Bao M. Expression of Th17/Treg Cells in Peripheral Blood and Related Cytokines of Patients with Ulcerative Colitis of Different Syndrome Types and Correlation with the Disease. Evid Based Complement Alternat Med 2021;2021:4600947. [PMID: 34603468 DOI: 10.1155/2021/4600947] [Reference Citation Analysis]
10 Laugesen K, Ludvigsson JF, Schmidt M, Gissler M, Valdimarsdottir UA, Lunde A, Sørensen HT. Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries. Clin Epidemiol 2021;13:533-54. [PMID: 34321928 DOI: 10.2147/CLEP.S314959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Halliday G, Porter RJ, Black CJ, Arends MJ, Din S. c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions. World J Gastroenterol 2022; 28(13): 1338-1346 [DOI: 10.3748/wjg.v28.i13.1338] [Reference Citation Analysis]
12 Ward D, Neumann A, Hendel JW, Riis LB, Tøttrup A, Jess T, Aalykke C. Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. [DOI: 10.1080/00365521.2021.2022191] [Reference Citation Analysis]
13 Forss A, Clements M, Bergman D, Roelstraete B, Kaplan GG, Myrelid P, Halfvarson J, Olén O, Ludvigsson JF. A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014. Aliment Pharmacol Ther 2021. [PMID: 34907544 DOI: 10.1111/apt.16735] [Reference Citation Analysis]
14 Lucafò M, Curci D, Franzin M, Decorti G, Stocco G. Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention. Front Pharmacol 2021;12:772101. [PMID: 34744751 DOI: 10.3389/fphar.2021.772101] [Reference Citation Analysis]
15 Burisch J, Lophaven S, Munkholm P, Langholz E. Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohort. Aliment Pharmacol Ther 2021. [PMID: 34713926 DOI: 10.1111/apt.16677] [Reference Citation Analysis]
16 Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci 2021;22:11365. [PMID: 34768795 DOI: 10.3390/ijms222111365] [Reference Citation Analysis]
17 Yao D, Dai W, Dong M, Dai C, Wu S. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis. EBioMedicine 2021;74:103751. [PMID: 34902790 DOI: 10.1016/j.ebiom.2021.103751] [Reference Citation Analysis]
18 Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.Dtsch Arztebl Int. 2020;117:564-574. [PMID: 33148393 DOI: 10.3238/arztebl.2020.0564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ouryemchi M, Jabi R, Soussan H, Najioui Y, Bouziane M. Degenerative Ulcerative Colitis After One Year of Evolution in a 20-Year-Old Patient. Cureus 2021;13:e18582. [PMID: 34760425 DOI: 10.7759/cureus.18582] [Reference Citation Analysis]
20 Han JX, Tao ZH, Qian Y, Yu CY, Li J, Kang ZR, Lu S, Xie Y, Hong J, Chen H, Chen YX, Fang JY. ZFP90 drives the initiation of colitis-associated colorectal cancer via a microbiota-dependent strategy. Gut Microbes 2021;13:1-20. [PMID: 33947304 DOI: 10.1080/19490976.2021.1917269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Voskens CJ, Stoica D, Roessner S, Vitali F, Zundler S, Rosenberg M, Wiesinger M, Wunder J, Siegmund B, Schuler-Thurner B, Schuler G, Berking C, Atreya R, Neurath MF. Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial. BMJ Open 2021;11:e049208. [PMID: 34880013 DOI: 10.1136/bmjopen-2021-049208] [Reference Citation Analysis]
22 Gordon C, Chee D, Hamilton B, Heerasing NM, Hendy P, Chanchlani N, Lin S, Wesley E, Daniels IR, Silva N, Osborne M, Kennedy NA, Goodhand JR, Ahmad T. Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2021;53:291-301. [PMID: 33159472 DOI: 10.1111/apt.16155] [Reference Citation Analysis]
23 Wang L, Ji T, Yuan Y, Fu H, Wang Y, Tian S, Hu J, Wang L, Wang Z. High-fructose corn syrup promotes proinflammatory Macrophage activation via ROS-mediated NF-κB signaling and exacerbates colitis in mice. International Immunopharmacology 2022;109:108814. [DOI: 10.1016/j.intimp.2022.108814] [Reference Citation Analysis]
24 Ou AT, Zhang JX, Fang YF, Wang R, Tang XP, Zhao PF, Zhao YG, Zhang M, Huang YZ. Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases. Acta Pharmacol Sin 2020;42:1913-20. [PMID: 34561552 DOI: 10.1038/s41401-021-00770-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sasson AN, Sheehan G, Yu A, Gupta A, Ling K, Kochar B, Ananthakrishnan AN. Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative Colitis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00899-5. [PMID: 34425278 DOI: 10.1016/j.cgh.2021.08.019] [Reference Citation Analysis]
26 Quaglio AEV, Santaella FJ, Rodrigues MAM, Sassaki LY, Di Stasi LC. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers. World J Gastroenterol 2021; 27(45): 7801-7812 [PMID: 34963743 DOI: 10.3748/wjg.v27.i45.7801] [Reference Citation Analysis]
27 Li Y, Pan X, Yin M, Li C, Han L. Preventive Effect of Lycopene in Dextran Sulfate Sodium-Induced Ulcerative Colitis Mice through the Regulation of TLR4/TRIF/NF-κB Signaling Pathway and Tight Junctions. J Agric Food Chem 2021;69:13500-9. [PMID: 34729976 DOI: 10.1021/acs.jafc.1c05128] [Reference Citation Analysis]
28 Saitta D, Garg M. Letter: missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease-still significant room for improvement. Aliment Pharmacol Ther 2021;54:734-5. [PMID: 34379837 DOI: 10.1111/apt.16521] [Reference Citation Analysis]
29 Iwaya M, Ota H, Nakajima T, Uehara T, Riddell R, Conner J. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma. BMC Cancer 2021;21:119. [PMID: 33541282 DOI: 10.1186/s12885-021-07835-3] [Reference Citation Analysis]
30 Guan Y, Hao Y, Guan Y, Bu H, Wang H. Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis. Eur J Nutr 2021. [PMID: 34075433 DOI: 10.1007/s00394-021-02603-2] [Reference Citation Analysis]
31 Cretara A, Knee A, Mueller J, Jawale R. Association Between Loss of SATB2 Expression in Inflammatory Bowel Disease Indefinite for Dysplasia and a Diagnosis of Definitive Dysplasia on Follow-up. Am J Surg Pathol 2022. [PMID: 35405720 DOI: 10.1097/PAS.0000000000001900] [Reference Citation Analysis]
32 Zhou X, Ren M, Yang J, Pan H, Yu M, Ji F. Curcumin Improves Epithelial Barrier Integrity of Caco-2 Monolayers by Inhibiting Endoplasmic Reticulum Stress and Subsequent Apoptosis. Gastroenterol Res Pract 2021;2021:5570796. [PMID: 34659400 DOI: 10.1155/2021/5570796] [Reference Citation Analysis]
33 Atia O, Harel S, Ledderman N, Greenfeld S, Kariv R, Dotan I, Balicer R, Silverman B, Matz E, Levi Z, Waterman M, Fried I, Rowe JM, Turner D. Risk of cancer in pediatric-onset inflammatory bowel diseases: A nation-wide study from the epi-IIRN. J Crohns Colitis 2021:jjab205. [PMID: 34791097 DOI: 10.1093/ecco-jcc/jjab205] [Reference Citation Analysis]
34 Burgueño JF, Fritsch J, González EE, Landau KS, Santander AM, Fernández I, Hazime H, Davies JM, Santaolalla R, Phillips MC, Diaz S, Dheer R, Brito N, Pignac-Kobinger J, Fernández E, Conner GE, Abreu MT. Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis. Gastroenterology 2021;160:797-808.e6. [PMID: 33127391 DOI: 10.1053/j.gastro.2020.10.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Hirsch D, Hardt J, Sauer C, Heselmeyer-Hadded K, Witt SH, Kienle P, Ried T, Gaiser T. Molecular characterization of ulcerative colitis-associated colorectal carcinomas. Mod Pathol 2021;34:1153-66. [PMID: 33318582 DOI: 10.1038/s41379-020-00722-5] [Reference Citation Analysis]
36 Fujita M, Suzuki H, Fukai F. Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression. World J Gastrointest Oncol 2021; 13(9): 980-994 [PMID: 34616507 DOI: 10.4251/wjgo.v13.i9.980] [Reference Citation Analysis]
37 Damião AOMC, Queiroz NSF. Medical Therapy in Chronic Refractory Ulcerative Colitis: When Enough Is Enough. Clin Colon Rectal Surg 2022;35:032-43. [DOI: 10.1055/s-0041-1740036] [Reference Citation Analysis]
38 He MM, Lo CH, Wang K, Polychronidis G, Wang L, Zhong R, Knudsen MD, Fang Z, Song M. Immune-Mediated Diseases Associated With Cancer Risks. JAMA Oncol 2021. [PMID: 34854871 DOI: 10.1001/jamaoncol.2021.5680] [Reference Citation Analysis]
39 Yang Q, Ouyang J, Sun F, Yang J. Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes. Front Immunol 2020;11:590685. [PMID: 33363537 DOI: 10.3389/fimmu.2020.590685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Guo Y, He X, Zhao RM, Yang HZ, Huang Z, Zhang J, Yu XQ. Zn-Dipicolylamine-based Reactive Oxygen Species-Responsive Lipids for siRNA Delivery and in vivo Colitis Treatment. Acta Biomater 2022:S1742-7061(22)00242-2. [PMID: 35489607 DOI: 10.1016/j.actbio.2022.04.033] [Reference Citation Analysis]
41 Takakura H, Horinaka M, Imai A, Aono Y, Nakao T, Miyamoto S, Iizumi Y, Watanabe M, Narita T, Ishikawa H, Mutoh M, Sakai T. Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells. J Clin Biochem Nutr . [DOI: 10.3164/jcbn.21-74] [Reference Citation Analysis]
42 Axelrad JE, Sachs MC, Ludvigsson JF, Olén O; SWIBREG Study Group. A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data. Clin Epidemiol 2020;12:1059-72. [PMID: 33116900 DOI: 10.2147/CLEP.S265404] [Reference Citation Analysis]
43 El-Matary W, Bernstein CN. Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease. Front Pediatr 2020;8:400. [PMID: 32903330 DOI: 10.3389/fped.2020.00400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Li F, Fu J, Fan L, Lu S, Zhang H, Wang X, Liu Z. Overexpression of circAtp9b in ulcerative colitis is induced by lipopolysaccharides and upregulates PTEN to promote the apoptosis of colonic epithelial cells. Exp Ther Med 2021;22:1404. [PMID: 34675997 DOI: 10.3892/etm.2021.10840] [Reference Citation Analysis]
45 Adamek HE, Hommelsheim A. [Intestinal and extraintestinal malignancies in inflammatory bowel disease: case series from a tertiary center]. Z Gastroenterol 2021. [PMID: 34820805 DOI: 10.1055/a-1672-4861] [Reference Citation Analysis]
46 Mouratidou N, Malmborg P, Järås J, Sigurdsson V, Sandström O, Fagerberg UL, Bröms G, Ludvigsson JF, Olén O; SWIBREG Study Group. Identification of Childhood-Onset Inflammatory Bowel Disease in Swedish Healthcare Registers: A Validation Study. Clin Epidemiol 2022;14:591-600. [PMID: 35520278 DOI: 10.2147/CLEP.S358031] [Reference Citation Analysis]
47 Sawayama H, Miyamoto Y, Yoshida N, Baba H. Essential updates 2020/2021: Colorectal diseases (benign)—Current topics in the surgical and medical treatment of benign colorectal diseases. Annals of Gastroent Surgery. [DOI: 10.1002/ags3.12548] [Reference Citation Analysis]
48 Taborelli M, Sozzi M, Del Zotto S, Toffolutti F, Montico M, Zanier L, Serraino D. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy. PLoS One 2020;15:e0235142. [PMID: 32574216 DOI: 10.1371/journal.pone.0235142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Chen Y, Han L, Qiu X, Wang G, Zheng J. Neutrophil Extracellular Traps in Digestive Cancers: Warrior or Accomplice. Front Oncol 2021;11:766636. [PMID: 34868992 DOI: 10.3389/fonc.2021.766636] [Reference Citation Analysis]
50 Tonelli F, Di Martino C, Amorosi A, Mini E, Nesi G. Surgery for ulcerative colitis complicated with colorectal cancer: when ileal pouch-anal anastomosis is the right choice. Updates Surg 2022. [PMID: 35217982 DOI: 10.1007/s13304-022-01250-4] [Reference Citation Analysis]
51 Lyu S, Pan F, Ge H, Yang Q, Duan X, Feng M, Liu X, Zhang T, Liu J. Fermented egg-milk beverage alleviates dextran sulfate sodium-induced colitis in mice through the modulation of intestinal flora and short-chain fatty acids. Food Funct 2021. [PMID: 34935826 DOI: 10.1039/d1fo03040j] [Reference Citation Analysis]
52 Lin V, Fransgaard T, Gögenur I. ASO Author Reflections: Does a Diagnosis of Ulcerative Colitis Affect Outcome in Colorectal Cancer? Ann Surg Oncol 2021. [PMID: 34432195 DOI: 10.1245/s10434-021-10698-4] [Reference Citation Analysis]
53 Kim MJ, Ko JS, Shin M, Hahn JW, Moon SY, Kim HY, Moon JS. Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series. BMC Pediatr 2021;21:504. [PMID: 34763671 DOI: 10.1186/s12887-021-02966-9] [Reference Citation Analysis]
54 Kanters A, Liska D. The Impact of Ulcerative Colitis on Colorectal Cancer Prognosis: The Jury is Still Out. Ann Surg Oncol 2022. [PMID: 35015182 DOI: 10.1245/s10434-021-11307-0] [Reference Citation Analysis]
55 Wan D, Wang S, Xu Z, Zan X, Liu F, Han Y, Jiang M, Wu A, Zhi Q. PRKAR2A‐derived circular RNAs promote the malignant transformation of colitis and distinguish patients with colitis‐associated colorectal cancer. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.683] [Reference Citation Analysis]
56 Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P, Barua I, Jodal HC, Melum E, Løberg M, Blom J, Bretthauer M, Adami HO, Kalager M, Ye W. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study. United European Gastroenterol J 2022. [PMID: 35107865 DOI: 10.1002/ueg2.12204] [Reference Citation Analysis]
57 Yang Q, Ouyang J, Pi D, Feng L, Yang J. Malassezia in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis. Front Immunol 2022;13:846469. [DOI: 10.3389/fimmu.2022.846469] [Reference Citation Analysis]
58 Troelsen FS, Sørensen HT, Pedersen L, Erichsen R. Risk of a post-colonoscopy colorectal cancer in patients with type 2 diabetes: a Danish population-based cohort study. BMJ Open Gastroenterol 2021;8:e000786. [PMID: 34952850 DOI: 10.1136/bmjgast-2021-000786] [Reference Citation Analysis]
59 Lewandowska A, Rudzki G, Lewandowski T, Stryjkowska-Góra A, Rudzki S. Title: Risk Factors for the Diagnosis of Colorectal Cancer. Cancer Control 2022;29:10732748211056692. [PMID: 35000418 DOI: 10.1177/10732748211056692] [Reference Citation Analysis]
60 Marquez-megias S, Nalda-molina R, Sanz-valero J, Más-serrano P, Diaz-gonzalez M, Candela-boix MR, Ramon-lopez A. Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review. Pharmaceutics 2022;14:1009. [DOI: 10.3390/pharmaceutics14051009] [Reference Citation Analysis]
61 Yadav A, Jena A, Arpitha K, Shah J, Vaiphei K, Dutta U, Singh AK. Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease. Inflamm Bowel Dis 2022:izac033. [PMID: 35230448 DOI: 10.1093/ibd/izac033] [Reference Citation Analysis]
62 Charkaoui M, Hajage D, Tubach F, Laurent B, Kirchgesner J. Impact of anti-tumor necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study. J Crohns Colitis 2021:jjab184. [PMID: 34657962 DOI: 10.1093/ecco-jcc/jjab184] [Reference Citation Analysis]
63 Penate Medina T, Pan J, Damoah C, Humbert J, Köpnick A, Will O, Sebens S, Penate Medina O. Utilizing Sphingomyelinase Sensitizing Liposomes in Imaging Intestinal Inflammation in Dextran Sulfate Sodium-Induced Murine Colitis. Biomedicines 2022;10:413. [DOI: 10.3390/biomedicines10020413] [Reference Citation Analysis]
64 Everhov ÅH, Bruze G, Söderling J, Askling J, Halfvarson J, Westberg K, Malmborg P, Nordenvall C, Ludvigsson JF, Olén O. Women's Earnings are more Affected by Inflammatory Bowel Disease than Men's: A Register-Based Swedish Cohort Study. J Crohns Colitis 2021;15:980-7. [PMID: 33245360 DOI: 10.1093/ecco-jcc/jjaa238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Pastille E, Faßnacht T, Adamczyk A, Ngo Thi Phuong N, Buer J, Westendorf AM. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer. Front Immunol 2021;12:669747. [PMID: 34025672 DOI: 10.3389/fimmu.2021.669747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]